What does CUSIP 00972D105 represent in this 13F holders report?

CUSIP 00972D105 is the security identifier for AKBA - Akebia Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AKBA - Akebia Therapeutics, Inc. - Common Stock in Q2 2020?

184 institutional investors reported AKBA - Akebia Therapeutics, Inc. - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

Akebia Therapeutics, Inc. - Common Stock (AKBA)

CUSIP: 00972D105

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 263,222,327
Total 13F shares: 111,597,128
Share change: +18,825,554
Total reported value: $1,515,160,970
Put/Call ratio: 27%
Price per share: $13.58
Number of holders: 184
Value change: +$263,628,807
Number of buys: 122
Number of sells: 55

Quarterly Holders Quick Answers

What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 00972D105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAUPOST GROUP LLC/MA	13F	Company	6.7%	17,527,968	$132,862,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	3.9%	10,134,619	$76,820,000	—	31 Mar 2020	13F
Consonance Capital Management LP	13F	Company	2.7%	7,121,283	$53,979,000	—	31 Mar 2020	13F
Nantahala Capital Management, LLC	13F	Company	2.5%	6,559,478	$49,721,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	2.2%	5,885,554	$44,613,000	—	31 Mar 2020	13F
ABRAMS CAPITAL MANAGEMENT, L.P.	13F	Company	2.1%	5,656,462	$42,876,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	1.3%	3,416,930	$25,900,000	—	31 Mar 2020	13F
Novo Holdings A/S	13F	Company	1.3%	3,393,039	$25,719,000	—	31 Mar 2020	13F
Point72 Asset Management, L.P.	13F	Company	0.75%	1,974,320	$14,965,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.7%	1,844,423	$13,981,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.69%	1,824,766	$13,831,000	—	31 Mar 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.66%	1,725,541	$13,080,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.56%	1,485,856	$11,263,000	—	31 Mar 2020	13F
Clearbridge Investments, LLC	13F	Company	0.56%	1,472,436	$11,161,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.56%	1,467,877	$11,126,000	—	31 Mar 2020	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.53%	1,407,164	$10,666,000	—	31 Mar 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.5%	1,311,965	$9,945,000	—	31 Mar 2020	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.47%	1,250,000	$9,475,000	—	31 Mar 2020	13F
Invesco Ltd.	13F	Company	0.43%	1,135,256	$8,605,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	0.39%	1,026,067	$7,778,000	—	31 Mar 2020	13F
NORGES BANK	13F	Company	0.35%	920,031	$6,974,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.33%	860,215	$6,520,000	—	31 Mar 2020	13F
DAFNA Capital Management LLC	13F	Company	0.32%	853,538	$6,470,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.29%	772,252	$5,854,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.28%	742,612	$5,629,000	—	31 Mar 2020	13F
Woodline Partners LP	13F	Company	0.24%	626,710	$4,750,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.22%	591,076	$4,480,000	—	31 Mar 2020	13F
PKO Investment Management Joint-Stock Co	13F	Company	0.21%	547,302	$4,148,549	—	31 Mar 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.19%	497,758	$3,773,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.18%	479,997	$3,638,000	—	31 Mar 2020	13F
Artal Group S.A.	13F	Company	0.16%	425,000	$3,222,000	—	31 Mar 2020	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.14%	355,754	$2,697,000	—	31 Mar 2020	13F
Stanley-Laman Group, Ltd.	13F	Company	0.12%	319,073	$2,419,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.1%	263,480	$1,997,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.09%	242,353	$1,837,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.09%	236,902	$1,796,000	—	31 Mar 2020	13F
Atom Investors LP	13F	Company	0.09%	224,769	$1,704,000	—	31 Mar 2020	13F
Squarepoint Ops LLC	13F	Company	0.08%	221,109	$1,676,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.08%	219,281	$1,662,000	—	31 Mar 2020	13F
Man Group plc	13F	Company	0.08%	219,106	$1,661,000	—	31 Mar 2020	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.08%	217,123	$1,646,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.08%	214,691	$1,627,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.08%	205,338	$1,558,000	—	31 Mar 2020	13F
Integral Health Asset Management, LLC	13F	Company	0.08%	200,000	$1,516,000	—	31 Mar 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.07%	182,234	$1,381,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.07%	178,308	$1,352,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.07%	177,382	$1,346,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.06%	162,111	$1,229,000	—	31 Mar 2020	13F
UBS Group AG	13F	Company	0.06%	157,487	$1,194,000	—	31 Mar 2020	13F
Hudson Bay Capital Management LP	13F	Company	0.06%	155,000	$1,175,000	—	31 Mar 2020	13F

Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q2 2020

As of 30 Jun 2020, Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by 184 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 111,597,128 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Consonance Capital Management LP, Nantahala Capital Management, LLC, ABRAMS CAPITAL MANAGEMENT, L.P., STATE STREET CORP, GREAT POINT PARTNERS LLC, and D. E. Shaw & Co., Inc.. This page lists 184 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

150

Q2 2020 holders

184

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.